0.4648
price down icon0.04%   -0.0002
 
loading
전일 마감가:
$0.465
열려 있는:
$0.4592
하루 거래량:
723.82K
Relative Volume:
0.74
시가총액:
$137.22M
수익:
$54,000
순이익/손실:
$-210.26M
주가수익비율:
-0.5884
EPS:
-0.79
순현금흐름:
$-159.01M
1주 성능:
-14.12%
1개월 성능:
-33.94%
6개월 성능:
-61.90%
1년 성능:
-77.76%
1일 변동 폭
Value
$0.44
$0.4966
1주일 범위
Value
$0.44
$0.568
52주 변동 폭
Value
$0.44
$3.145

Lyell Immunopharma Inc Stock (LYEL) Company Profile

Name
명칭
Lyell Immunopharma Inc
Name
전화
650 695-0677
Name
주소
201 HASKINS WAY, SOUTH SAN FRANCISCO
Name
직원
300
Name
트위터
Name
다음 수익 날짜
2025-03-12
Name
최신 SEC 제출 서류
Name
LYEL's Discussions on Twitter

LYEL을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
LYEL
Lyell Immunopharma Inc
0.4648 137.22M 54,000 -210.26M -159.01M -0.79
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
474.62 121.88B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
573.45 62.69B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
555.11 33.86B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
235.74 30.51B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
238.51 25.69B 3.81B -644.79M -669.77M -6.24

Lyell Immunopharma Inc Stock (LYEL) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-10-30 다운그레이드 BofA Securities Buy → Underperform
2024-06-27 다운그레이드 H.C. Wainwright Buy → Neutral
2023-08-28 다운그레이드 JP Morgan Overweight → Neutral
2022-11-14 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2022-11-11 다운그레이드 Goldman Buy → Neutral
2022-10-17 개시 H.C. Wainwright Buy
2021-07-12 개시 BofA Securities Buy
2021-07-12 개시 Goldman Buy
2021-07-12 개시 JP Morgan Overweight
2021-07-12 개시 Morgan Stanley Overweight
모두보기

Lyell Immunopharma Inc 주식(LYEL)의 최신 뉴스

pulisher
Apr 02, 2025

Lyell Immunopharma director Otis Brawley purchases shares for $19,958 - Investing.com India

Apr 02, 2025
pulisher
Apr 02, 2025

Lyell Immunopharma stock hits 52-week low at $0.48 - Investing.com

Apr 02, 2025
pulisher
Apr 02, 2025

Lyell Immunopharma stock hits 52-week low at $0.48 By Investing.com - Investing.com South Africa

Apr 02, 2025
pulisher
Apr 01, 2025

Lyell Immunopharma to close West Hills facility, cut 73 jobs - Investing.com

Apr 01, 2025
pulisher
Apr 01, 2025

Lyell Immunopharma’s LyFE Center Begins IMPT-314 Production - TipRanks

Apr 01, 2025
pulisher
Apr 01, 2025

Lyell Immunopharma IncTo Close West Hills Manufacturing FacilitySEC Filing - MarketScreener

Apr 01, 2025
pulisher
Mar 31, 2025

Lyell Immunopharma, Inc. (NASDAQ:LYEL) Sees Significant Decline in Short Interest - MarketBeat

Mar 31, 2025
pulisher
Mar 31, 2025

Charles Schwab Investment Management Inc. Has $1.05 Million Holdings in Lyell Immunopharma, Inc. (NASDAQ:LYEL) - Defense World

Mar 31, 2025
pulisher
Mar 28, 2025

Is Lyell Immunopharma, Inc. (LYEL) the Cheapest Stock Insiders Are Buying In March? - Insider Monkey

Mar 28, 2025
pulisher
Mar 25, 2025

Lyell Immunopharma director Ramachandra Sumant purchases $115,219 in stock - Investing.com

Mar 25, 2025
pulisher
Mar 25, 2025

Lyell Immunopharma director Ramachandra Sumant purchases $115,219 in stock By Investing.com - Investing.com South Africa

Mar 25, 2025
pulisher
Mar 23, 2025

Investor Interest in Lyell Immunopharma Stock (LYEL) Surges on Positive Analyst Report - markets.businessinsider.com

Mar 23, 2025
pulisher
Mar 20, 2025

Favourable Signals For Lyell Immunopharma: Numerous Insiders Acquired Stock - Yahoo Finance

Mar 20, 2025
pulisher
Mar 20, 2025

Chief Financial Officer of Lyell Immunopharma Charles Newton Buys 989% More Shares - simplywall.st

Mar 20, 2025
pulisher
Mar 19, 2025

How to interpret Lyell Immunopharma Inc (LYEL)’s stock chart patterns - US Post News

Mar 19, 2025
pulisher
Mar 19, 2025

Lyell Immunopharma stock hits 52-week low at $0.51 By Investing.com - Investing.com Australia

Mar 19, 2025
pulisher
Mar 19, 2025

Lyell Immunopharma director Richard Klausner purchases $94,942 in stock - Investing.com India

Mar 19, 2025
pulisher
Mar 18, 2025

Lyell Immunopharma CEO Seely Lynn buys $106,190 in stock By Investing.com - Investing.com South Africa

Mar 18, 2025
pulisher
Mar 18, 2025

Lyell Immunopharma director Richard Klausner purchases $94,942 in stock By Investing.com - Investing.com Canada

Mar 18, 2025
pulisher
Mar 18, 2025

Lyell Immunopharma CFO Newton purchases $111,620 in common stock By Investing.com - Investing.com South Africa

Mar 18, 2025
pulisher
Mar 18, 2025

Lyell Immunopharma CEO Seely Lynn buys $106,190 in stock - Investing.com India

Mar 18, 2025
pulisher
Mar 18, 2025

Lyell Immunopharma CFO Newton purchases $111,620 in common stock - Investing.com India

Mar 18, 2025
pulisher
Mar 18, 2025

Lyell Immunopharma stock hits 52-week low at $0.51 - Investing.com India

Mar 18, 2025
pulisher
Mar 18, 2025

Lyell Immunopharma’s Global Expansion Strategy: Navigating Risks and Challenges - TipRanks

Mar 18, 2025
pulisher
Mar 17, 2025

HC Wainwright Has Optimistic Outlook of LYEL Q1 Earnings - Defense World

Mar 17, 2025
pulisher
Mar 15, 2025

Lyell Immunopharma (NASDAQ:LYEL) Earns Neutral Rating from HC Wainwright - Defense World

Mar 15, 2025
pulisher
Mar 13, 2025

H.C. Wainwright maintains Neutral on Lyell Immunopharma stock By Investing.com - Investing.com Australia

Mar 13, 2025
pulisher
Mar 12, 2025

Lyell Immunopharma Advances CAR T-Cell Therapy Pipeline - TipRanks

Mar 12, 2025
pulisher
Mar 11, 2025

Lyell Immunopharma reports Q4 net loss $45.9M vs. net loss $44M last year - TipRanks

Mar 11, 2025
pulisher
Mar 11, 2025

Lyell Immunopharma Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2024 - GlobeNewswire

Mar 11, 2025
pulisher
Mar 11, 2025

Breakthrough: Lyell's Cancer Therapy Achieves 94% Response Rate Amid Q4 Financial Results - StockTitan

Mar 11, 2025
pulisher
Mar 06, 2025

BlackRock, Inc. Reduces Stake in Lyell Immunopharma Inc - GuruFocus.com

Mar 06, 2025
pulisher
Feb 20, 2025

Lyell Immunopharma (LYEL) Projected to Post Earnings on Wednesday - MarketBeat

Feb 20, 2025
pulisher
Feb 19, 2025

Lyell Immunopharma Announces Participation in Upcoming Investor Conferences - The Manila Times

Feb 19, 2025
pulisher
Feb 18, 2025

LYELLyell Immunopharma, Inc. Latest Stock News & Market Updates - StockTitan

Feb 18, 2025
pulisher
Feb 18, 2025

Cell Therapy Pioneer Lyell to Showcase Cancer Treatment Breakthroughs at Elite Investor Events - StockTitan

Feb 18, 2025
pulisher
Feb 18, 2025

What Did We Find About Insider Trading At Lyell Immunopharma Inc (NASDAQ: LYEL)? - Stocks Register

Feb 18, 2025
pulisher
Feb 17, 2025

Lyell Immunopharma (LYEL) Upgraded to Strong Buy: Here's Why - MSN

Feb 17, 2025
pulisher
Feb 17, 2025

Following a 67% decline over last year, recent gains may please Lyell Immunopharma, Inc. (NASDAQ:LYEL) institutional owners - Simply Wall St

Feb 17, 2025
pulisher
Feb 14, 2025

SG Americas Securities LLC Has $75,000 Position in Lyell Immunopharma, Inc. (NASDAQ:LYEL) - Defense World

Feb 14, 2025
pulisher
Feb 10, 2025

Market Recap Check: Lyell Immunopharma Inc (LYEL)’s Negative Finish at 0.57, Up/Down -2.94 - The Dwinnex

Feb 10, 2025
pulisher
Feb 07, 2025

Lyell Immunopharma Inc (LYEL) Stock: A Year of Market Fluctuations - The InvestChronicle

Feb 07, 2025
pulisher
Feb 06, 2025

Take off with Lyell Immunopharma Inc (LYEL): Get ready for trading - SETE News

Feb 06, 2025
pulisher
Feb 04, 2025

LYEL underperforms with a -0.98 decrease in share price - US Post News

Feb 04, 2025
pulisher
Feb 04, 2025

Market Momentum Report: Lyell Immunopharma Inc (LYEL)’s Negative Close at 0.58 - The Dwinnex

Feb 04, 2025
pulisher
Jan 31, 2025

Lyell Immunopharma, Inc. (NASDAQ:LYEL) has caught the attention of institutional investors who hold a sizeable 46% stake - Yahoo Finance

Jan 31, 2025
pulisher
Jan 25, 2025

Lyell Immunopharma Faces Nasdaq delisting over share price - MSN

Jan 25, 2025
pulisher
Jan 25, 2025

Lyell Immunopharma Faces Nasdaq delisting over share price By Investing.com - Investing.com Australia

Jan 25, 2025

Lyell Immunopharma Inc (LYEL) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$60.58
price down icon 3.01%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
자본화:     |  볼륨(24시간):